JPWO2023025215A5 - - Google Patents
Info
- Publication number
- JPWO2023025215A5 JPWO2023025215A5 JP2024512952A JP2024512952A JPWO2023025215A5 JP WO2023025215 A5 JPWO2023025215 A5 JP WO2023025215A5 JP 2024512952 A JP2024512952 A JP 2024512952A JP 2024512952 A JP2024512952 A JP 2024512952A JP WO2023025215 A5 JPWO2023025215 A5 JP WO2023025215A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- antibody
- binding portion
- cancer
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021114549 | 2021-08-25 | ||
| CNPCT/CN2021/114549 | 2021-08-25 | ||
| PCT/CN2022/114642 WO2023025215A1 (en) | 2021-08-25 | 2022-08-25 | ANTIBODIES AND VARIANTS THEREOF AGAINST HUMAN CD16a |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024532886A JP2024532886A (ja) | 2024-09-10 |
| JP2024532886A5 JP2024532886A5 (https=) | 2025-09-01 |
| JPWO2023025215A5 true JPWO2023025215A5 (https=) | 2025-09-01 |
Family
ID=85321557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024512952A Pending JP2024532886A (ja) | 2021-08-25 | 2022-08-25 | ヒトＣＤ１６ａに対する抗体及びその変異体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240352128A1 (https=) |
| EP (1) | EP4392453A4 (https=) |
| JP (1) | JP2024532886A (https=) |
| KR (1) | KR20240049331A (https=) |
| CN (1) | CN117858902A (https=) |
| WO (1) | WO2023025215A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120813603A (zh) * | 2023-03-03 | 2025-10-17 | 广州百济神州生物制药有限公司 | Cd16a抗体和使用方法 |
| KR20250156802A (ko) * | 2023-03-03 | 2025-11-03 | 비원 메디슨즈 아이 게엠베하 | Muc1 및 cd16a 항체 및 사용 방법 |
| WO2024206126A1 (en) * | 2023-03-27 | 2024-10-03 | Modernatx, Inc. | Cd16-binding antibodies and uses thereof |
| CN120025439B (zh) * | 2023-11-21 | 2026-04-17 | 南京融捷康生物科技有限公司 | 一种抗CD16a的单域抗体及其用途 |
| CN118221818B (zh) * | 2024-04-29 | 2025-01-24 | 四川大学 | 一种抗cd16a的纳米抗体及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60334453D1 (de) * | 2002-05-30 | 2010-11-18 | Macrogenics Inc | Cd16a bindungsproteine und verwendung zur behandlung von immunkrankheiten |
| GB0510790D0 (en) * | 2005-05-26 | 2005-06-29 | Syngenta Crop Protection Ag | Anti-CD16 binding molecules |
| US20070036786A1 (en) * | 2005-07-11 | 2007-02-15 | Nadine Tuaillon | Method of treating autoimmune disease using humanized anti-CD16A antibodies |
| WO2018039626A1 (en) * | 2016-08-25 | 2018-03-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Human single domain antibodies targeting cd16a to mediate adcc |
| CN110461357A (zh) * | 2017-02-28 | 2019-11-15 | 阿菲姆德股份有限公司 | 抗cd16a抗体与细胞因子的组合 |
| WO2022161314A1 (zh) * | 2021-01-27 | 2022-08-04 | 信达生物制药(苏州)有限公司 | 针对cd16a的单域抗体及其用途 |
-
2022
- 2022-08-25 EP EP22860561.4A patent/EP4392453A4/en active Pending
- 2022-08-25 CN CN202280057501.6A patent/CN117858902A/zh active Pending
- 2022-08-25 JP JP2024512952A patent/JP2024532886A/ja active Pending
- 2022-08-25 US US18/682,827 patent/US20240352128A1/en active Pending
- 2022-08-25 KR KR1020247009137A patent/KR20240049331A/ko active Pending
- 2022-08-25 WO PCT/CN2022/114642 patent/WO2023025215A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024096688A5 (https=) | ||
| JP2021524249A5 (https=) | ||
| KR101504770B1 (ko) | 내성 항원에 대항하는 활성 항체의 생산 방법, 상기 방법에 의해 생산된 항체 및 이의 용도 | |
| JP2020501531A5 (https=) | ||
| Zhu et al. | Multifunctional receptor-targeting antibodies for cancer therapy | |
| US12269877B2 (en) | Anti-notch3 antibodies | |
| JP2015509947A5 (https=) | ||
| JP2013227339A5 (https=) | ||
| JPWO2019224717A5 (https=) | ||
| JP2013502913A5 (https=) | ||
| WO2012057288A1 (ja) | 新規抗ｄｒ５抗体 | |
| JP2021528047A5 (https=) | ||
| JP2026041845A5 (https=) | ||
| JP2024016024A5 (https=) | ||
| JPWO2020237173A5 (https=) | ||
| JPWO2023025215A5 (https=) | ||
| CN110835372B (zh) | 一种靶向Frizzled7单克隆抗体及其制备方法与应用 | |
| CN112805297B (zh) | 抗人类pd-l1抗体及其用途 | |
| JPWO2022159984A5 (https=) | ||
| JPWO2020218951A5 (https=) | ||
| US20220265821A1 (en) | Composition and methods of targeting the pre-b cell receptor for the treatment of leukemias and lymphomas | |
| JPWO2021176424A5 (https=) | ||
| JPWO2016163433A1 (ja) | 抗ｆｇｆｒ２抗体と他剤を含む組成物 | |
| JPWO2023021187A5 (https=) | ||
| JPWO2023049999A5 (https=) |